Formulation, Development and Evaluation of Budesonide Oral Nano-sponges Using DOE Approach: In Vivo Evidences
Purpose: The prevalent types of idiopathic inflammatory bowel disease are ulcerative colitis (UC) and Crohn’s disease, which affects a large number of populations. Budesonide (BUD) is a glucocorticoid with potent anti-inflammatory activity but low systemic efficacy because of high receptor affinity...
Main Authors: | Amarjit Salunke, Neeraj Upmanyu |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2021-02-01
|
Series: | Advanced Pharmaceutical Bulletin |
Subjects: | |
Online Access: | https://apb.tbzmed.ac.ir/PDF/apb-11-286.pdf |
Similar Items
-
Anti Pneumococcal Activity of Azithromycin-Eudragit RS100 Nano-Formulations
by: Khosrou Adibkia, et al.
Published: (2016-09-01) -
Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers
by: El-Maghawry E, et al.
Published: (2020-06-01) -
Application of statistical design to evaluate critical process parameters and optimize formulation technique of polymeric nanoparticles
by: Pradipta Sarkar, et al.
Published: (2019-07-01) -
Formulation and Evaluation of Ondansetron HCl Nanoparticles for Transdermal Delivery
by: Amjed H Noor, et al.
Published: (2020-12-01) -
Budesonide-Loaded Guar Gum Microspheres for Colon Delivery: Preparation, Characterization and in Vitro/in Vivo Evaluation
by: Ye Liu, et al.
Published: (2015-01-01)